Zobrazeno 1 - 10
of 11
pro vyhledávání: '"A. V. Belostotskii"'
Autor:
A. V. Belostotskii, V. S. Arnautov, I. G. Lopukhov, E. V. Torshina, D. V. Reikhart, A. A. Globenko
Publikováno v:
Pharmaceutical Chemistry Journal. 51:954-959
The pharmacokinetics, bioequivalence, and safety of Femorix® (Valenta Pharm Co., Russia) and Aubagio® (SanofiWinthrop Industrie, France) film-coated tablets (14 mg) were compared in a double-blind randomized investigation in parallel groups of heal
Autor:
D. K. Vasil’ev, D. V. Reikhart, V. S. Arnautov, A. V. Belostotskii, A. V. Kapashin, A. A. Globenko
Publikováno v:
Pharmaceutical Chemistry Journal. 51:690-694
The bioavailability and pharmacokinetic parameters of film-coated Teraligen Retard (TR 20, 40, and 60 mg at doses of 20, 40, and 60 mg, respectively) and immediate-release film-coated Teraligen Valenta tablets (TV 5 mg at a dose of 20 mg) were compar
Publikováno v:
Pharmaceutical Chemistry Journal. 51:142-152
An HPLC method with mass-spectrometric detection was developed for simultaneous quantitative determination of chlormadinone acetate and ethinyl estradiol in human blood plasma. The sample preparation method included liquid—liquid extraction using h
Autor:
E. V. Torshina, A. V. Belostotskii, V. S. Artnautov, D. V. Reikhart, A. V. Kapashin, V. G. Kukes
Publikováno v:
Pharmaceutical Chemistry Journal. 50:394-403
Valenta Pharm Co. compared the pharmacokinetic parameters in healthy volunteers of three prototype tizanidine dosage forms (delayed-release 6-mg tablets) and the reference drug sirdalud (2-mg tablets for a total dose of 6 mg, three tablets). This all
Publikováno v:
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny. 24(4)
The analysis was implemented concerning main directions of development of health care manpower policy in Moscow. The activities are established related to improvement of actual situation with development of potential of medical personnel, increasing
Publikováno v:
Pharmaceutical Chemistry Journal. 49:477-480
The bioavailabilities of two medicinal formulations of fampridine – fampridine slow-release tablets, 10 mg (study agent, OAO Valenta Farmatsevtika, Russia) and Fampyra slow-release tablets, 10 mg (reference agent, Biogen Idec Ltd., UK) were compare
Publikováno v:
European Journal of Anaesthesiology. 24:101
Publikováno v:
Polymer Mechanics. 12:746-751
1. The experimentally observed course of heat capacity is explained by competition of contributions from the lattice and defects, on one hand, and from retarded rotators, on the other.
Publikováno v:
Journal of Engineering Physics. 24:607-610
Formulas are derived for calculating the error in temperature measurements which results from a distortion of the temperature field by temperature or thermal flux probes.
Publikováno v:
Polymer Mechanics. 9:506-508
A procedure is suggested for determining the thermophysical properties of solids under hydrostatic pressure conditions by the instantaneous cylindrical heat source method without allowance for heat exchange at the sample-liquid boundary. A calculatio